Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 4/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | NOTUM | Q6P988 | 10/20 | 0.47 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.43 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3961321 | 0.83 | HSD17B3 (0.49) | HSD17B3GAASMN1; SMN2AVPR1ABRPF1 | |
| SCHEMBL3115822 | 0.82 | HSD17B3 (0.60) | HSD17B3GAASMN1; SMN2NOTUMAVPR1A | |
| SCHEMBL30529514 | 0.82 | HSD17B3 (0.60) | HSD17B3GAASMN1; SMN2NOTUMAVPR1A | |
| SCHEMBL31345695 | 0.81 | HSD17B3 (0.47) | HSD17B3GAASMN1; SMN2AVPR1ABRPF1 | |
| SCHEMBL7614532 | 0.81 | HSD17B3 (0.47) | HSD17B3GAASMN1; SMN2AVPR1ABRPF1 | |
| SCHEMBL3421961 | 0.81 | HSD17B3 (0.47) | HSD17B3GAASMN1; SMN2AVPR1ABRPF1 | |
| SCHEMBL29556642 | 0.81 | HSD17B3 (0.47) | HSD17B3GAASMN1; SMN2NOTUMAVPR1A | |
| Hydrochloric Acid SCHEMBL736324 | 0.80 | HSD17B3 (0.46) | HSD17B3GAASMN1; SMN2AVPR1ABRPF1 | |
| SCHEMBL3988629 | 0.79 | HSD17B3 (0.45) | HSD17B3GAASMN1; SMN2AVPR1ABRPF1 | |
| SCHEMBL3089343 | 0.78 | SMN1; SMN2 (0.46) | HSD17B3GAASMN1; SMN2NOTUMAVPR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5719141-A | HYPOTENSIVE AGENTS | NOVARTIS CORPORATION (US) | 1998-02-17 | — | — | US | disclosed |
| EP-0702004-A2 | 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amid derivatives | CIBA-GEIGY AG (CH) | 1996-03-20 | — | — | EP | disclosed |